Glenmark Life Sciences standalone net profit declines 5.52% in the March 2022 quarter

21 Apr 2022 , 08:02 AM

Net profit of Glenmark Life Sciences declined 5.52% to Rs 98.90 crore in the quarter ended March 2022 as against Rs 104.68 crore during the previous quarter ended March 2021. Sales rose 10.04% to Rs 514.06 crore in the quarter ended March 2022 as against Rs 467.16 crore during the previous quarter ended March 2021.

For the full year,net profit rose 19.10% to Rs 418.72 crore in the year ended March 2022 as against Rs 351.58 crore during the previous year ended March 2021. Sales rose 12.63% to Rs 2123.21 crore in the year ended March 2022 as against Rs 1885.17 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	514.06	467.16	10	2123.21	1885.17	13
OPM %	27.67	36.36	–	29.02	31.35	–
PBDT	147.19	149.04	-1	602.80	504.34	20
PBT	137.64	140.61	-2	564.92	470.95	20
NP	98.90	104.68	-6	418.72	351.58	19

Powered by Capital Market – Live News